Enzyme Replacement Therapy in a Patient with Gaucher Disease Type III: A Paradigmatic Case Showing Severe Adverse Reactions Started a Long Time After the Beginning of Treatment

Vairo, Filippo; Netto, Cristina; Dorneles, Alicia; Mittelstadt, Suzana; Wilke, Matheus; Doneda, Divair; Michelin, Kristiane; Ribeiro, Camila Blos; Quevedo, Amanda; Vieira, Tatiane; Nalin, Tatiele; Lueska, Sônia; Schwartz, Ida Vanessa D.

Published in

JIMD Reports, p. 1-6

DOI: 10.1007/8904_2013_214

Tools

Export citation

Search in Google Scholar

Enzyme Replacement Therapy in a Patient with Gaucher Disease Type III: A Paradigmatic Case Showing Severe Adverse Reactions Started a Long Time After the Beginning of Treatment

Journal article published in 2013 by Filippo Vairo, Cristina Netto, Alicia Dorneles, Suzana Mittelstadt, Matheus Wilke, Divair Doneda, Kristiane Michelin, Camila Blos Ribeiro, Amanda Quevedo, Tatiane Vieira, Tatiele Nalin, Sônia Lueska, Ida Vanessa D. Schwartz

This paper is available in a repository.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Abstract

Introduction: There are three recombinant enzymes available for the treatment of Gaucher disease (GD): imiglucerase, velaglucerase alfa, and taliglucerase alfa.

Published in

Links

Tools

Enzyme Replacement Therapy in a Patient with Gaucher Disease Type III: A Paradigmatic Case Showing Severe Adverse Reactions Started a Long Time After the Beginning of Treatment

Abstract